Non Platinum Metal Complexes as Anti‐cancer Drugs
Top Cited Papers
- 5 March 2007
- journal article
- review article
- Published by Wiley in Archiv der Pharmazie
- Vol. 340 (3), 117-126
- https://doi.org/10.1002/ardp.200600151
Abstract
The development of metal complexes with platinum central atoms such as cisplatin or carboplatin had an enormous impact on current cancer chemotherapy. However, the spectrum of cancers that can be treated with platinum agents is narrow and treatment efficacy suffers from side effects and resistance phenomena. These unresolved problems in platinum‐based anti‐cancer therapy have stimulated increased research efforts in the search for novel non platinum‐containing metal species as cytostatic agents. Preclinical and clinical investigations showed that the development of new metal agents with modes of action different from cisplatin is possible. Thus, complexes with iron, cobalt, or gold central atoms have shown promising results in preclinical studies and compounds with titanium, ruthenium, or gallium central atoms have already been evaluated in phase I and phase II trials. This review covers some relevant examples of preclinical and clinical research on novel non platinum metal complexes.Keywords
This publication has 104 references indexed in Scilit:
- Tumorhemmende Metallverbindungen: Entwicklung, Bedeutung und PerspektivenPharmazie in unserer Zeit, 2006
- Redox behavior of tumor-inhibiting ruthenium(iii) complexes and effects of physiological reductants on their binding to GMPDalton Transactions, 2006
- Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Labeling of Biomolecules for Medicinal Applications—Bioorganometallic Chemistry at Its BestAngewandte Chemie, 2001
- Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast CancerOncology Research and Treatment, 2000
- Thioredoxin Reductase Activity Is Decreased by Selenium DeficiencyBiochemical and Biophysical Research Communications, 1997
- Bioorganometallic Chemistry – Synthesis and Antitumor Activity of Cobalt Carbonyl ComplexesArchiv der Pharmazie, 1997
- Tumor cell toxicity of stable gallium nitrate: Enhancement by transferrin and protection by ironEuropean Journal of Cancer and Clinical Oncology, 1982
- Relationship of iron metabolism to tumor cell toxicity of stable gallium saltsInternational Journal of Nuclear Medicine and Biology, 1981
- Acetylenic Dicobalt Hexacarbonyls. Organometallic Compounds Derived from Alkynes and Dicobalt Octacarbonyl1,2Journal of the American Chemical Society, 1956